Skip to content

Efficiency of Monitoring and Control Program of Hypertension Through Pharmacy Offices. APOF Project

Efficiency Program Monitoring and Control of Hypertension Through Pharmacy Offices. APOF Project

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02032472
Acronym
APOF
Enrollment
677
Registered
2014-01-10
Start date
2010-01-31
Completion date
2012-12-31
Last updated
2014-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Blood Pressure Monitoring, Ambulatory, Arterial Pressure, Hypertension Controlled, Pharmacies

Brief summary

Background: Hypertension in adults is the factor most prevalent cardiovascular risk and motivates further inquiries, generating a very high cost of medical care. Objective: To evaluate the monitoring of well-controlled hypertensive patients Pharmacy Offices. Hypothesis: the monitoring of these patients through the Office of Pharmacy will be as effective in obtaining good control of blood pressure as it is to obtained through health centers. Design: Multicenter randomized controlled trial along one year of follow up. Location: the city of Cerdanyola del Vallès (Barcelona). Participants: All patients diagnosed with hypertension and good control criteria in the past year. Arms: Health centers (control) and Pharmacy Offices (intervention). Outcome variable: blood pressure under good control along the monitoring

Interventions

OTHERMeasurement of Arterial Pressure

Pharmacies cooperate in measuring blood pressure of patients

Sponsors

Institut Catala de Salut
CollaboratorOTHER_GOV
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age not less than 18 years * HTA controlled over 2 years of evolution * Subjects with a history open to participating health centers or stable residence in the geographic area * Subjects who agree to participate

Exclusion criteria

* Comorbidity and concomitant (Diabetes Mellitus, Heart failure or renal failure * Patients with temporary residence in the geographic area of study * Subjects of hypertension controlled by outside professionals to our primary care teams. * Subjects with home care or any other cause which does not permit their displacement, transfer to the clinic or pharmacy during the evaluation period. * Subjects with severe diseases of poor prognosis, hopefully less than one year of life. * Subjects who do not have telephones. * Subjects with communication problems (cognitive impairment, sensory, language barrier)

Design outcomes

Primary

MeasureTime frameDescription
Percentage of hypertensive patients with criteria for good control of their arterial pressure along one year follow upMonitoring of patients for 12 months (from January 1 to December 31, 2010)We considered as a for good control criterion , obtaining values of systolic arterial pressure to below 140 mm Hg and diastolic blood pressure below 90 mm Hg dea, held along the entire the year follow-up of patients

Secondary

MeasureTime frameDescription
reduction in the number of visits to the health center to measure blood pressureMonitoring of patients for 12 months (from January 1 to December 31, 2010)The number of visits to the health center where blood pressure is measured. We hope that the number of visits to the health center where blood pressure is measured is lower in the intervention group (the patients have the option to go to the pharmacy to carrying out checks blood pressure)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026